Dogwood Therapeutics News

3: Initial statement of beneficial ownership of securities-10% Owner Sealbond Ltd

Oct 17 16:33 ET

3: Initial statement of beneficial ownership of securities-Director Yu Ying Choi Alan Abel

Oct 17 16:32 ET

3: Initial statement of beneficial ownership of securities-Director Toh Kean Meng Melvin

Oct 17 16:31 ET

SC 13D: Statement of acquisition of beneficial ownership by individuals-Sealbond Limited(15.9%),CK Life Sciences Int’l., (Holdings) Inc.(15.9%)

Oct 15 16:25 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pridgen William

Feb 28 13:23 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Thomas John C

Feb 28 13:13 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Whitley Richard James

Feb 28 13:08 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Keefer David R

Feb 28 13:03 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Burch Richard Alan

Feb 28 12:58 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director De La Rosa Abel

Feb 28 12:58 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walsh Angela

Feb 28 12:53 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Grosswald Ralph

Feb 28 12:53 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gendreau Roger Michael

Feb 28 12:48 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Duncan Gregory Scott

Feb 28 12:43 ET

Virios Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Brian Corday(4.6%)

Feb 13 18:06 ET

Virios Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Brian Corday(6.84%)

Nov 14, 2023 13:40 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pridgen William

Aug 22, 2023 15:57 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-CHIEF EXECUTIVE OFFICER Duncan Gregory Scott

Aug 18, 2023 07:05 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Keefer David R

Jun 20, 2023 14:06 ET

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director De La Rosa Abel

Jun 20, 2023 14:03 ET